Carlisle Cos. (CSL) Misses Q3 EPS by 5c, provides outlook
Get Alerts CSL Hot Sheet
Price: $367.68 +2.83%
Financial Fact:
Research and development expenses: 12.3M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development expenses: 12.3M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Carlisle Cos. (NYSE: CSL) reported Q3 EPS of $5.78, $0.05 worse than the analyst estimate of $5.83. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.38 billion.
2024 Fourth Quarter Outlook
Revenues to increase LSD
CCM - up MSD
CWT - down LSD
Adjusted EBITDA margin ~ 25%
For earnings history and earnings-related data on Carlisle Cos. (CSL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- Kotak Upgrades Narayana Hrudayalaya Ltd (NARH:IN) to Buy (1)
- HSBC Downgrades Kakao Corp. (035720:KS) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share